Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


People In Brief

This article was originally published in The Gray Sheet

Executive Summary

Abiomed resignation: Chief Financial Officer Daniel J. Sutherby left the cardiac assist device firm Oct. 1, according to an Oct. 2 Securities and Exchange Commission filing, which identifies Ian McLeod, Abiomed's corporate controller, as acting CFO. On the following day, the company reaffirmed its fiscal year 2009 revenue guidance of $75-$80 million, up from $58.9 million in fiscal 2008. While the resignation is "not ideal," said Morgan Stanley device analyst David R. Lewis, it is probably more reflective of changing strategic needs in the company following the June launch of the Impella 2.5 assist device (1"The Gray Sheet" June 9, 2008, p. 20), rather than "any ominous development.

You may also be interested in...

Abiomed Markets Impella 2.5 Cardiac Assist Device To Cath Labs

Abiomed is targeting its Impella 2.5 cardiac assist device at the top 300 interventional cardiology labs in the United States, firm CEO Michael Minogue said in a June 2 conference call announcing the market launch

Covidien Faces Challenge Of Accelerating Growth After Spin-Off From Tyco

Newly independent medical technology firm Covidien plans select acquisitions and divestitures as well as increased licensing activity to help accelerate growth following its June 29 spin-off from parent company Tyco International

Akorn Defaults On Loan Agreement After Sale Bid Falls Flat

Facing soaring legal costs stemming from its failed merger with Fresenius Kabi and burdened by substantial debt, Akorn elected to put itself up for sale earlier this year in order to help repay lenders. But the company has now defaulted on an agreement with its creditors after no bidder stepped up to the plate.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts